Curious About IV Infusion? — anuncio de VYEPTI® (eptinezumab-jjmr)

Prescribing Info: https://bit.ly/3szvhyc Discover VYEPTI, the 1st and only FDA-approved intravenous (IV) infusion for the preventive treatment of migraine in adults. VYEPTI is administered as a 30-minute IV infusion, once every 3 months, as a preventive treatment for migraine in adults. It is given by a healthcare provider, and total appointment time may vary. VYEPTI is a prescription medicine used for the preventive treatment of migraine in adults. Do not receive VYEPTI if you are allergic to eptinezumab-jjmr or any of the ingredients in VYEPTI. Allergic reactions, high blood pressure, and Raynaud's phenomenon can happen or worsen after receiving VYEPTI. Contact your healthcare provider if symptoms occur. The most common side effects of VYEPTI include stuffy nose and scratchy throat, and allergic reactions. Talk to your healthcare provider to see if VYEPTI is right for you. Video Description: A mom and son dance in a living room beneath a message highlighting VYEPTI dosing frequency. The video transitions to a message noting that VYEPTI may help prevent migraine attacks and introduces the VYEPTI infusion regimen, an IV treatment administered for 30 minutes 4 times a year (every 3 months) for the preventive treatment of migraine in adults. The video concludes encouraging viewers to learn more about the VYEPTI migraine infusion.